RxSight to Participate in the Wells Fargo Healthcare Conference
RxSight, Inc. (NASDAQ: RXST) will participate in the virtual Wells Fargo Healthcare Conference on September 10, 2021, at 12:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight, Inc. (NASDAQ: RXST) will participate in the virtual Wells Fargo Healthcare Conference on September 10, 2021, at 12:00 PM ET. Investors can access a live and archived webcast via the Investors section of the company's website. RxSight focuses on enhancing patients' vision post-cataract surgery with its Light Adjustable Lens system, the first of its kind that allows customization for improved visual acuity. The system now includes ActivShield technology for UV protection, further innovating ophthalmic treatments.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was -0.52%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, today announced plans to participate in the upcoming virtual Wells Fargo Healthcare Conference.
RxSight’s management is scheduled to present Friday, September 10, 2021, at 12:00pm ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.rxsight.com/
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
IR@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.